Congratulations to Dr Fabio Boylan and Dr Bashaer Alsharif on the publication of their recent paper on the clinical outcomes of using glucosinolates in the treatment of obesity.
Glucosinolates are the natural compounds that give cruciferous vegetables (members of the 'mustard' family, such as broccoli, cabbage, kale and radishes) their very distinctive taste. However, these compounds also help gut bacteria turn into active substances such as sulforaphane, an antioxidant and anti-inflammatory. In lab studies, they show promise in helping to reduce new fat cell formation, boosting energy burning, and calming the inflammation that often comes with excess weight.
In this paper, the researchers review the current clinical evidence on glucosinolates and their potential role in obesity management, examining their effects on body weight and related metabolic outcomes. They also discuss the opportunities and limitations of translating the promising biological effects of glucosinolates into effective clinical interventions.
It's important to remember that real-world results from people eating vegetables are much more modest and inconsistent. This is partly because gut bacteria vary a lot from person to person, and cooking methods produce different results (raw or lightly steamed works better than well-cooked). Vegetables — especially broccoli and brussels sprouts — are a safe, sensible addition to your diet and may give a small metabolic boost, but they're not a fix on their own and must form part of a balanced diet along with exercise.
📝 Always check with your doctor or pharmacist before trying any concentrated supplements, especially if you take other medications or have a thyroid condition.
It is a great pleasure to see this work published, and an exciting contribution to the growing evidence base on the potential of dietary bioactive compounds in tackling obesity.
The paper can be viewed here.